## Critical Parameters Checklist (from the protocol)

- Temperatures: 37°C incubation throughout; 43°C for plasmid integration; 30°C for plasmid loss; 55°C for pigment extraction step.
- Times:
  - TSA streak: 24 h + overnight
  - Growth monitoring: OD measurements every 2 h up to 24 h; 4.75–5 h for H2O2 assay; 48 h plates for pigment assay; 7 h biofilms for NO assay; 26 h TSA plates for NO assay; 7 day murine infection.
  - DAF-FM staining: 1 h at 37°C
  - H2O2 treatment: 2 h at 37°C
  - Methanol pigment extraction vortex 10 sec, incubate 5 min at 55°C.
- Volumes:
  - Shake flask ratios: aerobic 1:10 volume-to-flask; low-oxygen 7:10 volume-to-flask.
  - 1 ml culture sampling in various assays.
  - 200 µl aliquots for 96-well plate assays.
  - 420 µl methanol for pigment extraction.
- Concentrations:
  - Antibiotics: chloramphenicol 5 or 10 mg/ml; erythromycin 2 or 10 mg/ml; ampicillin and kanamycin 50 mg/ml each (for E. coli).
  - H2O2: 250 mM for oxidative stress assay.
  - DAF-FM diacetate: 5 mM.
  - DEA and DEA/NO: 100 mM.
  - cPTIO: 150 mM.
- Shaking speed: 250 rpm for aerobic growth.
- Static growth for low oxygen (0 rpm).
- OD600 starting points for growth curves: 0.02 or 0.05 as indicated.

## Potential Missing Parameters (compare to source)

- Initial OD600 for seeding cultures in growth/assays occasionally unspecified or variable between 0.02 and 0.05; clarification would be prudent.
- Exact centrifugation speeds/times for general harvesting steps frequently omitted or only general (e.g., 3 min at 13,000 rpm); RCF not specified—could vary by centrifuge model.
- Incubation temperature for plating serial dilutions sometimes unspecified.
- For mutant construction, some molecular cloning enzymatic reaction timings are not detailed but may be standard; e.g., time for ligations “several hours,” room temperature incubation.
- No experimental details on atmosphere (e.g., % O2, CO2) beyond static or shaking and flask ratios.
- Buffer compositions other than commercially named (e.g., HBSS) or chemical suppliers are missing full composition or catalog info.
- DAF-FM diacetate concentration used for plate assays (5 mM) is high relative to typical use (usually µM range); source indicates 5 mM but may warrant [CHECK].
- For NO detection, incubation details using DEA/NO and duration unspecified beyond 1-hour DAF-FM staining.
- Temperature and time for DNA digestion with Turbo DNase not fully described.
- No specification of animal housing conditions beyond standard laboratory.
- No mention of randomization or blinding in animal experiments.

## Possible Unsupported Claims

- The protocol states that saPDT "does not appear to function in an antioxidant capacity" based on H2O2 assay; however, the source indicates only “under the in vitro conditions tested,” hence the statement should be qualified to avoid overgeneralization.
- The claim that "endogenous NO levels on TSA plates appear upregulated" is based on DAF-FM assay showing ~35% decrease in nos mutant fluorescence; however, source states other cellular NO/RNS sources may contribute, so causality of saNOS solely responsible is not fully supported.
- The suggestion that carotenoid pigmentation increase in nos mutant is "solely due to loss of saNOS function" is not fully supported because pdt role is not ruled out conclusively in all contexts; polar effect could confound phenotype.
- The assumption that DAF-FM diacetate staining directly measures NO specifically, while source indicates reaction with RNS can occur, thus the protocol should qualify this as indirect detection.
- Statements about in vivo relevance of saNOS in MSSA virulence are based on murine sepsis model results but do not address partial polar effects on pdt expression in nos mutant; this caveat should be made explicit.
- The statement "Increased pigmentation is not due to altered expression of several pigment-related genes" is based on qPCR of only three genes and under specific growth conditions; full regulatory network changes are not excluded.

## Step Order / Omission Risks

- The protocol appears complete and generally consistent with source text step order.
- Potential omission: lack of explicit step describing verification of RNA integrity and absence of DNA contamination before qRT-PCR; only mock PCR mentioned.
- Complementation strain creation steps do not explicitly mention selecting for plasmid maintenance in complemented mutants during assays (e.g., antibiotic presence during phenotypic tests).
- In DAF-FM NO detection assays for plate-grown cells, no step describes adjusting for cell density differences explicitly before fluorescence normalization [CHECK].
- No mention of pre-staining washing steps to remove extracellular DAF-FM diacetate which may influence fluorescence background.
- Animal experiments lack detail about euthanasia method timing after pre-moribund state observed; humane endpoints criteria are summarized but specific handling steps may help reproducibility.
- No mention of negative controls or mock stains in fluorescence assays beyond stated reagents; could be emphasized for clarity.

---

Overall, the generated protocol reproduces the key experimental parameters and is consistent with the source text but some numeric details and caveats present in the source are not fully reflected. The claims should be qualified with regard to assay limitations and possible polar effects in mutants. Some minor procedural clarifications and explicit steps could reduce risk of variability.